| Table of contents Farm Hosp. vol.46 n.3 Toledo May./Jun. 2022 Press Release | | | |
Editorial | | | | · Precision medicine in chronic lymphatic leukemia: cost-effectiveness analysis of the new targeted therapies Briones, Javier
| | | Originals | | | | · Vancomycin versus daptomycin for the treatment of confirmed gram-positive catheter-related bloodstream infections in oncology patients del Rosario-García, Betel; Nazco-Casariego, Gloria Julia; Gómez-Sirvent, Juan Luis; García-Marrero, Rosa; García-Rosado, Dácil; López-Lirola, Ana María; Oramas-Rodríguez, Juana María; González-García, Jonathan
| | | | · Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies Montoro-Ronsano, José Bruno; Poveda-Andrés, José Luis; Romero-Garrido, José Antonio; López-Chicheri Barrena, Blanca; Alberto Vella, Vincenzo
| | | | · The risk of treatment-induced QT interval prolongation Chaverri-Fernández, José Miguel; Díaz-Madriz, José Pablo; Zavaleta-Monestel, Esteban; Cordero-García, Eugenia; Fallas-Mora, Abigail; Escalona-Rodríguez, Rocío
| | | | · Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain Moreno-Martínez, Estela; de la Serna-Torroba, Javier; Escudero-Vilaplana, Vicente; Hernández-Rivas, José Ángel; Sánchez-Cuervo, Marina; Sánchez-Hernández, Raquel
| | | | · Medicines in exceptional circumstances for solid tumours: focusing on evidence, effectiveness, and toxicity profiles Artiles-Medina, Alberto; Sáchez-Cuervo, Marina; Gómez-Dos Santos, Victoria; Sanz-Álvarez, Emilio J; Álvarez-Díaz, Ana; Burgos-Revilla, Francisco Javier
| | | | · Use of tracking drugs for the search of intra-hospital adverse reactions: a pharmacovigilance study Corrêa-Benedet-Baesso, Kely; Zapelini-do Nascimento, Diego; de Sá-Soares, Alessandra; Schuelter-Trevisol, Fabiana
| | | | · Reactogenicity of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19 in workers of a tertiary hospital Palomo-Palomo, Cristina; Guerra-Estévez, Dulce; Parrado-González, Alberto; Estaire-Gutiérrez, Julia; Reyes-Malia, Miguel; Romero-Alonso, M Mercedes
| | | | · Concordance between expectations and preferences of patients and evaluation criteria of the European Medicines Agency Gil-Sierra, Manuel David; Briceño-Casado, María del Pilar; Arias-Arias, Ángel Jesús; Martín-Rodríguez, Santiago
| | | Reviews | | | | · Systematic review and meta-analysis of interleulin-6 inhibitors in reducing mortality for hospitalized patients with COVID-19 Alegre-del-Rey, Emilio Jesús; Fénix-Caballero, Silvia; Salmerón-Navas, Francisco Javier; Gil-Sierra, Manuel David; Sierra-Sánchez, Jesús Francisco; Díaz-Alersi-Rosety, Ramón L
| | | | · Patient-reported outcomes and mobile applications. A review of their impact on patients' health outcomes Collado-Borrell, Roberto; Escudero-Vilaplana, Vicente; Narrillos-Moraza, Álvaro; Villanueva-Bueno, Cristina; Herranz-Alonso, Ana; Sanjurjo-Sáez, María
| | | | · Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients Sulaiman, Helmi; Roberts, Jason A; Abdul–Aziz, Mohd H
| | | Special Article | | | | · Evaluating board certification within international advance pharmacy practice frameworks Lawson, Brian E; Guiu-Segura, Josep M
| | | Clinical Cases | | | | · Inclusion of omalizumab in a trastuzumab desensitization protocol Barreiro-Fernández, Ester María; Gil-Sierra, Manuel David; Briceño-Casado, María del Pilar; Martínez-Díaz, Carmen; Ríos-Sánchez, Esmeralda
| | | Erratum | | | | · Erratum found in «Farmacia Hospitalaria. 2021;45(3):126-34» Tejedor-Tejada, Eduardo; Nieto-Guindo, Pablo; Tejedor-Tejada, Javier; Martínez-Velasco, Estrella; Gómez-Sánchez, Araceli
| | |
|